439.05
+14.50
+(3.42%)
As of 1:38:18 PM GMT+1. Market Open.
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 24 | 9 | 30 | 31 |
| Avg. Estimate | 2.79B | 2.81B | 10.88B | 11.82B |
| Low Estimate | 2.72B | 2.7B | 10.63B | 11.24B |
| High Estimate | 2.85B | 2.99B | 10.96B | 12.5B |
| Year Ago Sales | 2.52B | 2.69B | 9.87B | 10.88B |
| Sales Growth (year/est) | 10.63% | 4.35% | 10.26% | 8.65% |
EPS Trend
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| VX1.F | -- | -- | -- | -- |
| S&P 500 | 9.91% | 10.33% | 14.01% | 13.75% |
Upgrades & Downgrades
| Maintains | HC Wainwright & Co.: Buy to Buy | 1/31/2025 |
| Reiterates | Needham: Hold to Hold | 1/31/2025 |
| Downgrade | Wells Fargo: Overweight to Equal-Weight | 1/30/2025 |
| Maintains | Piper Sandler: Overweight to Overweight | 1/27/2025 |
| Reiterates | Cantor Fitzgerald: Overweight to Overweight | 1/24/2025 |
| Maintains | Wells Fargo: Overweight to Overweight | 1/10/2025 |
Related Tickers
YDO1.F Madrigal Pharmaceuticals, Inc.
322.80
-0.06%
0QF.F Moderna, Inc.
40.15
-0.83%
22UA.F BioNTech SE
117.20
-1.43%
ONT.L Oxford Nanopore Technologies plc
144.70
-0.07%
CVAC CureVac N.V.
3.8200
-1.29%
CYTK Cytokinetics, Incorporated
49.97
+2.71%
UTHR United Therapeutics Corporation
352.30
-5.49%
GPCR Structure Therapeutics Inc.
30.32
-1.40%
ADMA ADMA Biologics, Inc.
16.10
-1.71%
BNTX BioNTech SE
120.88
-0.23%